Article
Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System.
Annals of surgical oncology - 1 May 2026
Dzubnar Jessica M, Habel Laurel A, Jiang Sheng-Fang, Karlea Audrey, Hoodfar Elizabeth, Shim Veronica C
Abstract excerpt
BACKGROUND: Identification of germline pathogenic (PV) and likely pathogenic variants (LPV) can inform patients of their risk for breast cancer, empowering them to utilize risk-reducing strategies. National guidelines for germline testing are the same for invasive breast cancer (IBC) and ductal carcinoma in situ (DCIS); however, data on how testing and results compare for patients with DCIS versus IBC are...
Topics
- Humans
- Female
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
- Retrospective Studies
- Germ-Line Mutation
- Genetic Testing
- Carcinoma, Ductal, Breast
- Middle Aged
- Delivery of Health Care, Integrated
